News

Awards

06/2020
GATACA wins a commercialization award from Virginia's Center of Innovative Technology (CIT); now VIPC offers the first version of GAT/ML on the GATACA website.

GAT for NGS: A Bioinformatics Tool for HBV Quasispecies – Incorporating Machine Learning

03/2020
GATACA wins Phase I SBIR award from the NIH (NIAID) to develop machine learning features into GAT/ML.

Development of a joint machine learning/de novo assembly system for resolving viral quasispecies using hepatitis B virus (HBV) as the pilot test case.

02/2016
GATACA wins Phase I SBIR award from the NIH (NIAID) to develop GAT.

Development of a tool for the whole genome de novo assembly of hepatitis B virus (HBV) populations.

07/2012
GATACA wins SBIR matching funds award from the Center for Innovative Technology (CIT).
03/2012
GATACA wins Phase II SBIR award from the NIH (NIAID) to develop HepCbase (Web-Based).

Integrated software application for management of Hepatitis C Virus data.

03/2010
GATACA wins Phase I SBIR award from the NIH (NIAID) to develop a HepCbase desktop.

Desktop application for management and analysis of Hepatitis C Virus data.

01/2005
GATACA wins Phase I SBIR award from the NSF to develop HCV analytics.

Desktop tools for management of Hepatitis C Virus data.

Announcements

07/2023
The GAT/ML modules are now being advanced to learn human immunodeficiency virus (HIV) variation

GATACA conducts initial testing of GAT/ML on HIV patient sequences, showing that it distinguishes among major and minor HIV subtypes and recombinants, from full-length HIV genomes and the challenging envelope (env) gene.

12/2022
Invited presentation, 2022 HIV & Respi-DART conference

Francesco Strino, Fabio Parisi and Johanna C. Craig. A hybrid de novo viral assembly system for haplotype-resolved viral quasispecies. HIV & Respi-DART 2022.

08/2020
GAT/ML pipeline analyzes HBV patient NGS for case-study presentation and publication.

GATACA, in collaboration with the LOBP (Emory) and the University of São Paulo School of Medicine, co-authors an abstract that was presented at EASL, London, and a manuscript for publication:

Suzane K. Ono, Johanna C. Craig, Leda Bassit, Rodrigo M. Abreu, Lilia Ganova-Raeva, Yury Khudyakov, Dimitri Gonzalez, Flair J. Carrilho, Raymond F. Schinazi. Multivariant surface quasispecies in a hepatitis B virus chronically infected individual with concomitant and continually positive surface antigen and anti-HBs biomarkers. 2020. EMJ European Medical Journal. 8[Suppl 2]:37-39.

11/2018
GATACA releases Application Note announcing new de novo GAT for HBV.

Presented at the 2018 Annual Forum for HBV Research in Washington D.C.

07/2017
GATACA co-authors publication on HCV.

Impact of IFNL4 rs12979860 and rs8099917 polymorphisms on response to Peg-Interferon-α and Ribavirin in patients with a congenital bleeding disorder and chronic hepatitis C.

Keshvari M., Alavian S.M., Behnava B., Pouryasin A., Craig J.C., Sharafi H. J Clin Lab Anal. 2017 Jul;31(4).

05/2013
GATACA is invited to join the Bioinformatics Working Group of The Forum for Collaborative HIV Research.

GATACA becomes a member of interactive bioinformatics roundtable meetings, and HepCbase served as the hub for the upload and management of HIV NGS data.